Foundation Medicine and Other Catagories

Videos — September 28, 2015


At this point, Foundation Medicine is exclusively an oncology company, but our next-generation sequencing technique, which can deep sequence hundreds of genes with world class laboratory capability and world class computational biology capability, certainly has potential applicability.

Immunotherapy comes to mind. Immunotherapy, now, is an up and coming area of cancer therapy.

We will start to look at immune genes and immune therapy. This could have applicability to autoimmune diseases, for instance, outside of cancer. I think the answer is “Yes, this technique could very well be valuable in diseases other than cancer.”

Related Articles

Subscribe to
Oncology Practice Management

Stay up to date with oncology news & updates by subscribing to recieve the free OPM print publications or weekly e‑Newsletter.

I'd like to recieve: